ASX - By Stock
|
PAA |
Re:
Ann: PharmAust's Phase 1 Study Data Presented at Major Conference
|
|
ThriftyClown
|
21 |
6.4K |
35 |
18/06/24 |
18/06/24 |
ASX - By Stock
|
21
|
6.4K
|
35
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Appointment of Non-Executive Director
|
|
ThriftyClown
|
45 |
10K |
34 |
17/06/24 |
17/06/24 |
ASX - By Stock
|
45
|
10K
|
34
|
|
ASX - By Stock
|
PAA |
Re:
Ann: OLE Study update reveals impressive Survival Data
|
|
ThriftyClown
|
206 |
52K |
25 |
05/06/24 |
05/06/24 |
ASX - By Stock
|
206
|
52K
|
25
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial
|
|
ThriftyClown
|
563 |
136K |
27 |
30/05/24 |
30/05/24 |
ASX - By Stock
|
563
|
136K
|
27
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Investor update
|
|
ThriftyClown
|
86 |
21K |
12 |
17/05/24 |
17/05/24 |
ASX - By Stock
|
86
|
21K
|
12
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
ThriftyClown
|
1.4K |
363K |
11 |
16/05/24 |
16/05/24 |
ASX - By Stock
|
1.4K
|
363K
|
11
|
|
ASX - By Stock
|
PAA |
Re:
Corporate action
|
|
ThriftyClown
|
239 |
64K |
16 |
06/05/24 |
06/05/24 |
ASX - By Stock
|
239
|
64K
|
16
|
|
ASX - By Stock
|
PAA |
Re:
Corporate action
|
|
ThriftyClown
|
239 |
64K |
26 |
05/05/24 |
05/05/24 |
ASX - By Stock
|
239
|
64K
|
26
|
|
ASX - By Stock
|
PAA |
Re:
Corporate action
|
|
ThriftyClown
|
239 |
64K |
19 |
04/05/24 |
04/05/24 |
ASX - By Stock
|
239
|
64K
|
19
|
|
ASX - By Stock
|
PAA |
Re:
PAA TOP HOLDERS MOVEMENTS AS AT 30 APRIL 2024
|
|
ThriftyClown
|
19 |
6.0K |
9 |
01/05/24 |
01/05/24 |
ASX - By Stock
|
19
|
6.0K
|
9
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Appendix 4C & Quarterly Update
|
|
ThriftyClown
|
104 |
20K |
32 |
30/04/24 |
30/04/24 |
ASX - By Stock
|
104
|
20K
|
32
|
|
ASX - By Stock
|
PAA Biotech |
Re:
Walk to Defeat MND
|
|
ThriftyClown
|
32 |
10K |
18 |
28/04/24 |
28/04/24 |
ASX - By Stock
|
32
|
10K
|
18
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Resignation of Dr Michael Thurn & appointment of John Clark
|
|
ThriftyClown
|
261 |
72K |
33 |
23/04/24 |
23/04/24 |
ASX - By Stock
|
261
|
72K
|
33
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PharmAust makes Head of Manufacturing appointment
|
|
ThriftyClown
|
37 |
9.5K |
28 |
18/04/24 |
18/04/24 |
ASX - By Stock
|
37
|
9.5K
|
28
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Trading Halt
|
|
ThriftyClown
|
63 |
20K |
9 |
02/04/24 |
02/04/24 |
ASX - By Stock
|
63
|
20K
|
9
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Great Pharmaust FDA ODD Approval Sweepstake
|
|
ThriftyClown
|
222 |
48K |
9 |
22/03/24 |
22/03/24 |
ASX - By Stock
|
222
|
48K
|
9
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PharmAust to present at NWR Virtual Healthcare Conference
|
|
ThriftyClown
|
126 |
33K |
21 |
22/03/24 |
22/03/24 |
ASX - By Stock
|
126
|
33K
|
21
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Investor webinar - Phase 1 MND Study Top-Line Results
|
|
ThriftyClown
|
209 |
51K |
16 |
26/02/24 |
26/02/24 |
ASX - By Stock
|
209
|
51K
|
16
|
|
ASX - By Stock
|
PAA |
Re:
Ann: FDA Provides Clear Feedback for ODD Approval
|
|
ThriftyClown
|
323 |
77K |
30 |
24/02/24 |
24/02/24 |
ASX - By Stock
|
323
|
77K
|
30
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Extension Study Begins, Analysis Suggests Survival Benefit
|
|
ThriftyClown
|
197 |
53K |
10 |
21/02/24 |
21/02/24 |
ASX - By Stock
|
197
|
53K
|
10
|
|
ASX - By Stock
|
PAA |
Re:
Best ASX stock Pharmaust for the next 10 years
|
|
ThriftyClown
|
9 |
2.7K |
24 |
14/02/24 |
14/02/24 |
ASX - By Stock
|
9
|
2.7K
|
24
|
|
ASX - By Stock
|
PAA |
Re:
MY INPUT REGARDING PAA AND SARS-COV-2.
|
|
ThriftyClown
|
41 |
9.3K |
18 |
06/02/24 |
06/02/24 |
ASX - By Stock
|
41
|
9.3K
|
18
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Investor Presentation and Non-Deal Roadshow
|
|
ThriftyClown
|
11 |
3.7K |
25 |
05/02/24 |
05/02/24 |
ASX - By Stock
|
11
|
3.7K
|
25
|
|
ASX - By Stock
|
PAA |
Re:
Ann: FDA Provides Clear Feedback for ODD Approval
|
|
ThriftyClown
|
323 |
77K |
7 |
01/02/24 |
01/02/24 |
ASX - By Stock
|
323
|
77K
|
7
|
|
ASX - By Stock
|
PAA |
Re:
Ann: FDA Provides Clear Feedback for ODD Approval
|
|
ThriftyClown
|
323 |
77K |
7 |
01/02/24 |
01/02/24 |
ASX - By Stock
|
323
|
77K
|
7
|
|
ASX - By Stock
|
PAA |
Re:
Ann: FDA Provides Clear Feedback for ODD Approval
|
|
ThriftyClown
|
323 |
77K |
18 |
01/02/24 |
01/02/24 |
ASX - By Stock
|
323
|
77K
|
18
|
|
ASX - By Stock
|
PAA |
Re:
Ann: FDA Provides Clear Feedback for ODD Approval
|
|
ThriftyClown
|
323 |
77K |
14 |
31/01/24 |
31/01/24 |
ASX - By Stock
|
323
|
77K
|
14
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PAA completes Phase 1 and files for Orphan Drug Designation
|
|
ThriftyClown
|
430 |
110K |
14 |
25/01/24 |
25/01/24 |
ASX - By Stock
|
430
|
110K
|
14
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PharmAust Partners with Berry Consultants for MND Phase 2/3
|
|
ThriftyClown
|
98 |
24K |
16 |
17/01/24 |
17/01/24 |
ASX - By Stock
|
98
|
24K
|
16
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PharmAust Partners with Berry Consultants for MND Phase 2/3
|
|
ThriftyClown
|
98 |
24K |
23 |
17/01/24 |
17/01/24 |
ASX - By Stock
|
98
|
24K
|
23
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PharmAust Partners with Berry Consultants for MND Phase 2/3
|
|
ThriftyClown
|
98 |
24K |
21 |
16/01/24 |
16/01/24 |
ASX - By Stock
|
98
|
24K
|
21
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PAA completes Phase 1 and files for Orphan Drug Designation
|
|
ThriftyClown
|
430 |
110K |
22 |
12/01/24 |
12/01/24 |
ASX - By Stock
|
430
|
110K
|
22
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PAA completes Phase 1 and files for Orphan Drug Designation
|
|
ThriftyClown
|
430 |
110K |
30 |
11/01/24 |
11/01/24 |
ASX - By Stock
|
430
|
110K
|
30
|
|
ASX - By Stock
|
PAA |
Re:
Ann: FDA Grants PharmAust Pre-IND Meeting
|
|
ThriftyClown
|
61 |
17K |
22 |
02/01/24 |
02/01/24 |
ASX - By Stock
|
61
|
17K
|
22
|
|
ASX - By Stock
|
PAA |
Re:
Pharmaust brand name required
|
|
ThriftyClown
|
30 |
6.2K |
11 |
30/12/23 |
30/12/23 |
ASX - By Stock
|
30
|
6.2K
|
11
|
|
ASX - By Stock
|
PAA |
Re:
Pharmaust brand name required
|
|
ThriftyClown
|
30 |
6.2K |
8 |
28/12/23 |
28/12/23 |
ASX - By Stock
|
30
|
6.2K
|
8
|
|
ASX - By Stock
|
PAA |
Re:
Ann: FightMND Invites PharmAust to Apply for Phase 2/3 Funding
|
|
ThriftyClown
|
56 |
15K |
14 |
22/12/23 |
22/12/23 |
ASX - By Stock
|
56
|
15K
|
14
|
|
ASX - By Stock
|
PAA |
Re:
Ann: FightMND Invites PharmAust to Apply for Phase 2/3 Funding
|
|
ThriftyClown
|
56 |
15K |
20 |
22/12/23 |
22/12/23 |
ASX - By Stock
|
56
|
15K
|
20
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PharmAust Receives R&D Tax Incentive Refund
|
|
ThriftyClown
|
1 |
713 |
21 |
20/12/23 |
20/12/23 |
ASX - By Stock
|
1
|
713
|
21
|
|
ASX - By Stock
|
PAA Biotech |
Re:
FDA Application for Orphan Drug Designation , PAA, MPL
|
|
ThriftyClown
|
355 |
69K |
25 |
30/11/23 |
30/11/23 |
ASX - By Stock
|
355
|
69K
|
25
|
|
ASX - By Stock
|
PAA |
Re:
Trial Centre Monepantel Pharmaust
|
|
ThriftyClown
|
8 |
1.9K |
23 |
16/11/23 |
16/11/23 |
ASX - By Stock
|
8
|
1.9K
|
23
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PharmAust to present at Emerging ASX Gems Conference
|
|
ThriftyClown
|
82 |
18K |
14 |
08/11/23 |
08/11/23 |
ASX - By Stock
|
82
|
18K
|
14
|
|
ASX - By Stock
|
PAA Biotech |
Re:
FDA Application for Orphan Drug Designation , PAA, MPL
|
|
ThriftyClown
|
355 |
69K |
14 |
20/10/23 |
20/10/23 |
ASX - By Stock
|
355
|
69K
|
14
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Final MND Patient in Cohort 4 Successfully Completes Dosing
|
|
ThriftyClown
|
125 |
25K |
20 |
13/10/23 |
13/10/23 |
ASX - By Stock
|
125
|
25K
|
20
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Canine Oncology Data Supports Progression to Registration
|
|
ThriftyClown
|
91 |
19K |
15 |
09/10/23 |
09/10/23 |
ASX - By Stock
|
91
|
19K
|
15
|
|
Charts
|
PAA Biotech |
Re:
Mr Michael Thurn CEO Interview On Small Caps
|
|
ThriftyClown
|
57 |
15K |
8 |
24/09/23 |
24/09/23 |
Charts
|
57
|
15K
|
8
|
|
Charts
|
PAA Biotech |
Re:
Mr Michael Thurn CEO Interview On Small Caps
|
|
ThriftyClown
|
57 |
15K |
20 |
22/09/23 |
22/09/23 |
Charts
|
57
|
15K
|
20
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Additional Phase 1 data suggest MPL may inhibit MND
|
|
ThriftyClown
|
380 |
85K |
16 |
11/09/23 |
11/09/23 |
ASX - By Stock
|
380
|
85K
|
16
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Chief Executive Officer Appointment
|
|
ThriftyClown
|
95 |
23K |
19 |
04/09/23 |
04/09/23 |
ASX - By Stock
|
95
|
23K
|
19
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Additional Phase 1 data suggest MPL may inhibit MND
|
|
ThriftyClown
|
380 |
85K |
10 |
24/08/23 |
24/08/23 |
ASX - By Stock
|
380
|
85K
|
10
|
|